Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2019-01-11
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine recommended phase II dose and safety of
tetrathiomolybdate (TM) in combination with carboplatin and pemetrexed in chemo-naive
metastatic or recurrent non-squamous non-small cell lung cancer.